Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-703-86
Published November 24, 2021 · Recall initiated: November 4, 2021
Summary
FDA records drug Class II recall D-0234-2022, published November 24, 2021 and initiated November 4, 2021. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 15,88 bottles; Lot: Lot #: 07030002A, exp. date 02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amneal Pharmaceuticals of New York, LLC
- Distributor
- Product was distributed nationwide within the United States
- Lot
- Lot #: 07030002A, exp. date 02/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAExenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For SingleSeptember 30, 2026
- FDAMethylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: AmnealMay 8, 2024
- FDAVancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDCApril 24, 2024
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDAClonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: ActavisNovember 24, 2021
- FDAT4 EIA Kit, Cat No: BC-1007, Store at 2-8C, For in vitro diagnostic use only This product s intended use isNovember 17, 2021
Questions about this recall
Was Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-703-86 recalled?
Yes. FDA published recall D-0234-2022 on November 24, 2021. Reported hazard: Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
What should I do if I have this product?
Voluntary: Firm initiated · Letter